Most Popular Articles

21 April – 2 May

Abstracts of the 3rd World Parkinson Congress, October 1–4, 2013, Montréal, Canada 

Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016? 

Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? 

Variation in Recent Onset Parkinson’s Disease: Implications for Prodromal Detection 

“DBS means everything – for some time”. Patients’ perspectives on daily life with deep brain stimulation for Parkinson’s Disease 

 

1 April - 21 April

Abstracts of the 3rd World Parkinson Congress, October 1–4, 2013, Montréal, Canada
 
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
 
Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid
 
“DBS means everything – for some time”. Patients’ perspectives on daily life with deep brain stimulation for Parkinson’s Disease 
 
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases

 

26 March - 1 April

Abstracts of the 3rd World Parkinson Congress, October 1-4. 2013, Montreal, Canada

Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE 

The Concept of Prodromal Parkinson’s Disease 
 
The Synaptic Function of α-Synuclein 
 
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?